LIN LINDE PLC
Industrial Inorganic Chemicals · Nasdaq · SEC CIK 1707925 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.2%
TTM net income YoY-1.2%
TTM EPS YoY0.8%
Revenue 3-yr CAGR3.7%
Net income 3-yr CAGR5.4%
Margins
Gross margin47.9%
Operating margin25.3%
Net margin19.3%
FCF margin14.0%
EBITDA margin35.8%
Returns
ROE18.0%
ROA8.1%
ROIC (approx.)12.5%
Asset turnover0.42x
Leverage & solvency
Liabilities / assets53.5%
Debt / equity0.56x
Current ratio0.86x
Interest coverage35.51x
Cash quality & payout
Operating cash flow / net income1.53x
Accruals ratio-4.3%
Payout ratio41.6%
Capex / revenue15.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $9.40B | $9.29B | $8.78B | $8.76B | $8.62B | $8.49B | $8.11B | $8.28B |
| Cost of revenue | $4.96B | $4.86B | $4.52B | $4.55B | $4.38B | $4.31B | $4.16B | $4.32B |
| Gross profit | $4.44B | $4.43B | $4.26B | $4.22B | $4.24B | $4.19B | $3.96B | $3.96B |
| R&D expense | $37.00M | $37.00M | $38.00M | $35.00M | $36.00M | $38.00M | $38.00M | $39.00M |
| SG&A expense | $892.00M | $891.00M | $893.00M | $880.00M | $897.00M | $870.00M | $786.00M | $814.00M |
| Operating income | $2.15B | $2.55B | $2.44B | $2.02B | $2.37B | $2.35B | $2.18B | $2.27B |
| Interest expense | $71.00M | $61.00M | $62.00M | $64.00M | $64.00M | $67.00M | $60.00M | $53.00M |
| Pretax income | $2.13B | $2.55B | $2.43B | $2.01B | $2.36B | $2.35B | $2.18B | $2.26B |
| Income tax | $449.00M | $610.00M | $571.00M | $481.00M | $424.00M | $573.00M | $511.00M | $533.00M |
| Net income | $1.69B | $1.93B | $1.86B | $1.53B | $1.93B | $1.77B | $1.67B | $1.73B |
| EBITDA | $3.12B | $3.52B | $3.39B | $2.97B | $3.33B | $3.30B | $3.09B | $3.18B |
| EPS (basic) | 3.67 | 4.17 | 4.00 | — | 4.11 | 3.75 | 3.53 | — |
| EPS (diluted) | 3.66 | 4.15 | 3.98 | — | 4.09 | 3.73 | 3.51 | — |
| Dividends declared per share | 1.60 | 1.60 | 1.60 | 1.50 | 1.50 | 1.50 | 1.50 | 1.39 |
| Weighted avg. shares (diluted) | 462.51M | 464.52M | 466.32M | — | 471.51M | 473.57M | 476.26M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $3.95B | $4.90B | $3.96B | $5.06B | $4.51B | $4.79B | $5.29B | $4.85B |
| Receivables | $5.59B | $5.63B | $5.32B | $4.97B | $5.33B | $5.23B | $4.95B | $4.62B |
| Inventory | $2.13B | $2.12B | $2.08B | $2.06B | $2.13B | $2.12B | $1.98B | $1.95B |
| Current assets | $13.42B | $14.18B | $12.75B | $13.32B | $13.33B | $13.63B | $13.60B | $12.95B |
| PP&E, net | $29.83B | $29.17B | $28.56B | $28.26B | $27.54B | $26.93B | $25.71B | $24.77B |
| Goodwill | $27.90B | $27.93B | $27.88B | $27.93B | $27.83B | $27.81B | $26.51B | $25.94B |
| Intangibles | $11.43B | $11.56B | $11.67B | $11.87B | $11.93B | $12.08B | $11.56B | $11.33B |
| Total assets | $88.08B | $88.35B | $86.31B | $86.82B | $85.99B | $86.08B | $82.70B | $80.15B |
| Current liabilities | $15.64B | $16.13B | $15.39B | $15.20B | $16.19B | $14.71B | $14.48B | $14.54B |
| Short-term debt | $1.46B | $2.47B | $1.64B | $1.80B | $2.37B | $1.34B | $1.82B | $2.06B |
| Long-term debt | $20.59B | $20.68B | $19.86B | $20.68B | $18.59B | $19.70B | $17.61B | $15.34B |
| Total debt | $22.06B | $23.15B | $21.50B | $22.48B | $20.96B | $21.04B | $19.43B | $17.40B |
| Total liabilities | $47.08B | $47.72B | $46.22B | $47.08B | $45.91B | $46.09B | $43.24B | $40.66B |
| Shareholders' equity | $39.42B | $39.08B | $38.57B | $38.24B | $38.62B | $38.52B | $38.03B | $38.09B |
| Net debt | $18.11B | $18.25B | $17.54B | $17.42B | $16.45B | $16.25B | $14.14B | $12.55B |
| Cash flow statement | ||||||||
| Operating cash flow | $3.17B | $2.27B | $2.24B | $3.03B | $2.95B | $2.21B | $2.16B | $2.81B |
| Capital expenditure | $1.39B | $1.44B | $1.34B | $1.46B | $1.28B | $1.26B | $1.27B | $1.25B |
| Free cash flow | $1.78B | $833.00M | $898.00M | $1.57B | $1.67B | $954.00M | $891.00M | $1.56B |
| Investing cash flow | -$1.33B | -$1.66B | -$1.38B | -$1.46B | -$1.43B | -$1.46B | -$1.37B | -$1.38B |
| Financing cash flow | -$2.80B | $321.00M | -$1.97B | -$1.02B | -$1.78B | -$1.37B | -$388.00M | -$1.61B |
| Depreciation & amortization | $965.00M | $963.00M | $951.00M | $950.00M | $961.00M | $942.00M | $910.00M | $913.00M |
| Stock-based compensation | $44.00M | $19.00M | $41.00M | $31.00M | $45.00M | $46.00M | $42.00M | $40.00M |
| Dividends paid | $735.00M | $738.00M | $741.00M | $698.00M | $701.00M | $704.00M | $708.00M | $659.00M |
| Share buybacks | $954.00M | $871.00M | $807.00M | $1.39B | $989.00M | $1.11B | $1.11B | $1.33B |
Free plan shows the latest 8 periods; Pro shows all 39 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.